Germany-based Siemens Healthineers AG (ETR: SHL) released its results for the first quarter of fiscal year 2025, ended December 31, 2024. The company showcased an excellent equipment book-to-bill ratio of 1.21 and comparable revenue growth of 5.7%. This marks a strong start to the fiscal year, driven by growth across its business segments.
Business Segment Performance
By business segment, Imaging revenues increased 7.6% to EUR 3 billion (USD 3.1 billion), with an adjusted EBIT margin of 18.7% impacted by special items. Diagnostics revenues grew 1.6% to EUR 1.1 billion (USD 1.14 billion), with an adjusted EBIT margin of 7.8%. Varian revenues expanded 6.2% to EUR 1 billion (USD 1.03 billion), with an adjusted EBIT margin of 17.1%. Advanced Therapies revenues jumped 5.1% to EUR 499 million (USD 515 million), with an adjusted EBIT margin of 14.1%. The overall adjusted EBIT margin was 15.0%, above the prior-year quarter.
Fiscal Year 2025 Outlook
For fiscal year 2025, Siemens Healthineers expects comparable revenue growth of between 5% and 6% over fiscal year 2024. The company anticipates adjusted basic earnings per share in the range of EUR 2.35 to EUR 2.50. This outlook reflects Siemens Healthineers’ commitment to driving growth and innovation across its healthcare solutions.-Fineline Info & Tech
